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Nuclear Receptors: GR;Coregulators: CBP \| p300;Ligands: Corticosterone.

In the intact animal, the endogenous secretion of glucocorticoids (GC) from the adrenal gland occurs in a distinctive circhoral pattern with pulses at approximately hourly intervals ([@B1], [@B2]). This hormone profile interacts directly with individual stress responses ([@B3], [@B4]) and is modulated by physiological parameters, such as age, sex, and lactation ([@B5]), as well as pathophysiological processes associated with immunological, metabolic, cardiovascular, and affective dysfunction ([@B6], [@B7]). Because virtually every organ system in the body has GC receptor (GR) expression, it is important to understand how individual cells and tissues read the digital signal from pulses of GC hormones and indeed how they terminate their response when hormone levels rapidly diminish.

The classic static model of gene regulation involving prolonged binding of GR to DNA at specific GC regulatory elements (GRE) in target gene promoters has been superseded by a more dynamic model of nuclear receptor action ([@B8], [@B9]). Single cell imaging and fluorescent recovery after photobleaching technology have revealed that rapid chromatin exchange occurs in a timescale of seconds with GR binding causing chromatin remodeling and allowing a cycle of transcription to proceed. The chromatin transition results in ejection of GR from the DNA template, before GR can bind again ([@B10]--[@B12]). These studies have provided fascinating new insights into the real-time kinetics of GR interactions with the chromatin template, yet provide less information about the overlying slow cycling of the receptor at equilibrium position at individual DNA regulatory sites within the promoter regions of physiologically relevant "natural" target genes.

We have recently proposed that physiological GR function requires the ligand to be presented to target cells in discrete pulses, which are necessary for the establishment and maintenance of optimally regulated gene activation ([@B13]). We have shown that exposure of cells to pulses of their physiologically relevant ligand (cortisol for human HeLa cells and corticosterone for rat HTC and mouse AtT-20 cells) results in cyclical GR activation ([@B14]). In this manuscript, we now elucidate pulse-directed slow cycling of GR at GC regulatory regions in the promoters of the Period 1 (*PER1*), metallothionein I (*MT1*), tyrosine aminotransferase (*TAT*), and proopiomelanocortin (*POMC*) genes. Furthermore, we explore the mechanisms underlying the transcriptional pulsing phenomenon associated with the ultradian GC rhythm. GC pulse-directed cyclical regulation of the *PER1* gene has been pursued in specific detail, and we have found that the robust cyclical transcriptional activity of GR at the *PER1* gene involves cyclical actions of cAMP response element-binding protein (CREB) binding protein (CBP)/p300, rapid and reversible acetylation of histone H4, and cycles of RNA polymerase 2 (RNA Pol2) recruitment to the *PER1* promoter region. Finally, we report that the intranuclear chaperone cycle is a necessary and integral feature of the cyclical transcriptional activity at the *PER1* promoter. When the chaperone cycle is disrupted by heat shock protein 90 (HSP90) inhibition with geldanamycin (GA), pulsatile GR transcriptional activity is ablated at the primary step of ligand-induced GR activation. Subsequent steps of GR association with regulatory regions in the *PER1* promoter, recruitment of CBP/p300, increased acetylation status, and production of nascent RNA ceases in the absence of an intact molecular chaperone cycle.

Ours is the first report of ultradian GC rhythm-regulated cyclical activity of the histone acetyl transferases (HAT) CBP/p300, with remarkably rapid and reversible pulsatile changes in histone H4 acetylation status, consequent rhythmic changes in RNA Pol2 recruitment, and the associated pulsatile production of nascent RNA from a GC-target gene.

Results
=======

Ultradian GR slow cycling at the chromatin template
---------------------------------------------------

Three physiologically relevant and functionally diverse cell types, the pituitary-derived corticotroph AtT-20, the hepatocyte-derived HTC, and the cervical epithelial cancer cell HeLa, have previously been chosen to assess GR activation kinetics to pulses of natural GC. In all three cell lines, each pulse of GC hormone initiated a "wave" of GR activation and DNA association, which decreased rapidly after hormone washout, returning to baseline levels before addition of the next pulse 45 min later ([@B14]). Because these results measured GR binding to synthetic oligonucleotides containing the canonical GRE sequence, it was important to confirm the results using chromatin immunoprecipitation (ChIP) assay to measure GR association with GRE sites in "real" target genes. Therefore, we tested whether the endogenous ligands corticosterone and cortisol could also direct cycles of enhanced GR association with chromatin at specific GRE in natural GC-regulated gene promoters. Primers were designed to DNA regions flanking known GRE in the human *PER1* gene promoter, the mouse *MT1* gene promoter, the mouse POMC gene promoter, and the rat *TAT* gene promoter. Pulses of cortisol or corticosterone were applied to each relevant cell type (human HeLa cells for *PER1*, mouse pituitary corticotroph AtT-20 cells for *POMC* and *MT1*, and liver hepatoma HTC cells for *TAT*). Cells were fixed with 1% formaldehyde at defined time points throughout the time course, and ChIP assays were used to determine the net GR association detectable at each time point. A distinct pattern emerged from the ChIP studies, with GR oscillating between a predominantly chromatin-associated form and a predominately dissociated form ([Fig. 1](#F1){ref-type="fig"}). This pattern was evident at each of the regulatory DNA regions analyzed. Furthermore, the highly consistent pattern observed followed the temporal kinetics of GR activation determined by GRE oligonucleotide binding of prepared nuclear extracts in the TransAM assay ([@B14]). Interestingly, the dynamics of activated GR at the chromatin template were similar for all GRE tested, including the negative GRE of the GC repressed gene *POMC*. The rapid exchange of GR at the chromatin template ([@B15]) allows receptor to constantly sense intracellular hormone concentrations and respond quickly to the ultradian pulses of ligand. These highly responsive networks impose a distinctive temporal periodicity in regulation on GR action. The temporal regulation was conserved across four different genes, irrespective of whether they were induced or repressed by GC, as well as across three different species and cells derived from three different tissue types.

![Activated GR associates in a pulsatile fashion with the regulatory elements of GC target genes involved in HPA axis regulation, protein metabolism, basic cellular function, and peripheral clock resetting. *In vivo* ChIP assays showed that the same regime of pulses applied to each cell line caused cyclical changes in GR chromatin association activity at GRE of natural target gene promoters, including the GRE in the mouse *MT1* gene promoter in the AtT-20 line (A), human *PER1* gene promoter in the HeLa line (B), and the rat *TAT* in the HTC line (C), as well as the negative GRE of the mouse *POMC* gene promoter in the corticotroph-derived AtT-20 line (D).](zmg0061148340001){#F1}

Cyclical recruitment of CBP/p300 and pulsatile histone H4 acetylation during ultradian transcriptional regulation
-----------------------------------------------------------------------------------------------------------------

The Clock gene *PER1* has been particularly well characterized as a responsive target for pulsatile hormone treatment ([@B13], [@B16]). Therefore, *PER1* was chosen for a detailed study of the underlying mechanisms of its pulsatile transcriptional regulation. Generalized local acetylation status at the *PER1* promoter proximal GRE site was first assessed by ChIP, using antiacetylated lysine antibody. Local acetylation fluctuated significantly with each pulse of hormone addition, correlating well with the described transcriptional pulse profile. General acetylation increased at 15 min and was maximal at 30 min, relative to the start of each 15-min pulse ([Fig. 2](#F2){ref-type="fig"}A). This increased acetylation was rapidly reversible, decreasing to baseline levels by 60 min. Histone H4 is a known target for acetylation ([@B17]). Increased histone H4 acetylation is associated with recruitment of chromatin remodeling factors of the SWItch/Source NonFermentable family such as Brahma-related gene 1, which allows access of RNA Pol2 and auxiliary transcription machinery to the transcription start site ([@B18], [@B19]) and is often correlated with transcriptional activity ([@B20]). ChIP assay using a specific acetylated histone H4 antibody confirmed pulsatile acetylation of this structural nucleosome core protein ([Fig. 2](#F2){ref-type="fig"}B). The HAT complex members CBP and p300 were also assessed using ChIP and were found to undergo cyclical recruitment to the *PER1* GRE region ([Fig. 2](#F2){ref-type="fig"}, C and D). The pattern of both CBP and p300 recruitment closely tracked the GR slow cycling profile ([Fig. 2](#F2){ref-type="fig"}E) and in turn was closely followed by cyclical RNA Pol2 recruitment ([Fig. 2](#F2){ref-type="fig"}F). The pattern of cyclical Pol2 recruitment was consistent with our previously described pulses of *PER1* transcription in cell lines and rat liver ([@B13]) and rat hippocampus ([@B16]).

![Rapid and reversible acetylation of histone H4 at the PER1 promoter during cyclical recruitment of GR, CBP, p300, and RNA Pol2. A, An increase in generalized protein acetylation at the proximal GRE-containing region of the PER1 promoter was detected at 15 min and was maximal at 30 min, relative to the start of each 15-min pulse. B, ChIP assay using a specific acetylated histone H4 antibody confirmed H4 as an acetylation target. The HAT complex members CBP (C) and p300 (D) were both found to undergo cyclical recruitment to the PER1 GRE region. The pattern of both CBP and p300 recruitment closely tracked (E) the GR slow cycling profile and in turn was closely followed by (F) cyclical RNA Pol2 recruitment. P, Pulse; W, wash.](zmg0061148340002){#F2}

An exclusively intranuclear activity of GR is dependent on an intact HSP90 chaperone complex
--------------------------------------------------------------------------------------------

### Nuclear HSP90 sustains GR residence time and confers protection from proteasome-dependent nuclear clearance

Potential mechanisms for the dynamic responsiveness to pulsatile corticosterone administration were tested in the AtT-20 cell line. To test whether pulsatile GR responses were due to regulated nuclear cytoplasmic shuttling, high-powered analysis using the IN Cell 1000 Analyzer (GE Healthcare, Princeton, NJ) ([@B21]) was performed to quantitate GR cytoplasmic to nuclear translocation and nuclear retention kinetics. Initial studies with the IN Cell 1000 Analyzer revealed that constant corticosterone exposure resulted in rapid translocation of GR from the cytoplasm to the nucleus, with redistribution completed at 10--15 min of treatment onset (data not shown). Further incubation times of up to 60 min did not increase the nuclear/cytoplasmic ratio. Next, a single pulse of hormone was added to cells. Interestingly, nuclear GR levels remained maximal for several hours after hormone withdrawal ([Fig. 3](#F3){ref-type="fig"}) and then slowly cleared from the nucleus by 24 h consistent with previous reports in cultured cell experiments ([@B22]). Treatment with the HSP90 inhibitor GA, applied to the cells after the first pulse when GR nuclear translocation was complete, resulted in an increased clearance of GR from the nucleus during the acute phase of the time course (first 3 h of hormone withdrawal). The GA-induced accelerated nuclear GR clearance was reversed by preincubation with the specific 19S proteasome inhibitor MG132.

![HSP90 and the proteasome have opposing effects on GR nuclear retention in AtT-20 cells after a single corticosterone pulse. IN Cell 1000 analysis data presented graphically here show time (hours) after ligand withdrawal. The *solid trace* (*open circles*) represents corticosterone-treated cells, treated with vehicle after ligand washout. Here, GR was retained in the nucleus for up to 6 h after ligand washout. Clearance from the nucleus then occurred slowly and was complete by 24 h after ligand washout. The *dashed trace* (*filled triangles*) represents treatment with 1 μ[m]{.smallcaps} GA after the 15-min corticosterone pulse was washed from the cells (termed posttreatment). Inhibition of HSP90, after the GC pulse, resulted in an increased rate of clearance of GR from the nucleus. The effect of HSP90 posttreatment was reversed by preincubation of the cells with the proteasome inhibitor MG132; the *solid trace* (*stars*) represents preincubation with 10 μ[m]{.smallcaps} MG132 before the 15-min corticosterone pulse and GA posttreatment. The *dashed trace* (*open diamonds*) represents preincubation with 10 μ[m]{.smallcaps} MG132 before the 15-min corticosterone pulse, in the absence of GA treatment. MG132 appeared to affect both the GA-related, accelerated GR nuclear clearance as well as the slower naturally occurring GR nuclear clearance after hormone withdrawal.](zmg0061148340003){#F3}

Therefore, it appears that in the AtT-20 cell line, HSP90 and the related molecular chaperones act to protect GR from some form of proteasome-dependent clearance mechanism. Due to reports that the proteasome acts as a mobility factor ([@B23], [@B24]), we cannot rule out the possibility that the observed effect of MG132 is due to a lack of nuclear export resulting from immobilization of GR within the nucleus. However, the data strongly indicate that the HSP90 chaperone acts to effectively retain GR within the nucleus, suggesting that pulse responsiveness may occur in the intranuclear recycling loop first proposed by DeFranco and co-workers ([@B25]).

Ultradian activity of GR occurs in an exclusively intranuclear circuit
----------------------------------------------------------------------

To conclusively establish whether GR responsiveness to pulsatile GC treatment occurred independently of cytoplasmic transit, we examined whether the cyclic changes in GR activity required reimport of exported GR with each pulse of corticosterone. Treatment with okadaic acid, a nuclear translocation inhibitor for recycled cytoplasmic GR ([@B26]), did not decrease GR cyclical activity ([Fig. 4](#F4){ref-type="fig"}A). Similarly, treating AtT-20 cells with cyclohexamide (CHX), an inhibitor of *de novo* protein synthesis ([@B27]), did not reduce cycles of GR reactivation. Therefore, new synthesis of cytoplasmic GR was not necessary for pulsatile GR activity ([Fig. 4](#F4){ref-type="fig"}B). Finally, to ensure that all active transport through the nuclear pore was inhibited, cells were transfected with wheat germ agglutinin (WGA) using the protein transfection reagent Chariot (Active Motif, Carlsbad, CA) ([@B28]). WGA was delivered into the cells after nuclear translocation was complete but before the next pulse of corticosterone. Even when all active transit via the nuclear pore was inhibited, the GR activation-deactivation cycle continued during pulsatile GC treatment ([Fig. 4](#F4){ref-type="fig"}C). Experimental controls for the efficacy of CHX and WGA are shown in [Fig. 4](#F4){ref-type="fig"}, D and E, respectively.

![Each cycle of GR reactivation is exclusively intranuclear and does not require transit through the cytoplasm. A, Treatment with okadaic acid (OA) after nuclear translocation was complete had no effect on the subsequent cyclical waves of GR activation measured by TransAM GRE binding of nuclear extract prepared from cells at each indicated time point. B, CHX inhibition of *de novo* protein synthesis had no effect on the subsequent intranuclear GR cyclical DNA association activity. C, All active transport through the nuclear pore was inhibited by transfection of the cells with the lectin WGA using the protein transfection reagent Chariot (Active Motif) after the initial pulse-directed GR translocation is complete. Subsequent intranuclear cyclical DNA association activity was unaffected by WGA transfection. The bacterial protein β-galactosidase (β-GAL) was used as a transfection control. D, Protein extracts from cells treated with CHX in part (B) were Western blotted to PVDF membrane and probed for the GC-inducible leucine zipper protein (GILZ) to verify *de novo* protein synthesis had been ablated. Clearly, this dose of CHX inhibited expression of GILZ protein during the time course of the experiment. E, Transfection of WGA before the first pulse of corticosterone inhibited nuclear translocation of GR and GRE binding in the TransAM assay. P, Pulse; W, wash.](zmg0061148340004){#F4}

Pulsatile GR responsiveness depends on an intact nuclear chaperone complex
--------------------------------------------------------------------------

The molecular mechanism underlying the pulsatile hormone-directed slow cycling activity of GR and the subsequent effects on cyclical transcriptional activity at the PER1 gene were next addressed. Based on work that describes the HSP90 p23 molecular chaperone complex recruitment to GRE in rat liver HTC cells ([@B29]), we reasoned that the chaperone complex might play an integral role in GR transcriptional responsiveness to pulses of ligand. The chaperone complex centers around a direct HSP90-GR interaction, and the specific inhibitor of this interaction GA works rapidly within the timeframe of the physiological interpulse interval. Therefore, to test whether the chaperone complex is involved in pulsatile GR activity, GA was applied to cells during pulsatile GC exposure. It was surmised that if GR is reactivated by each pulse of corticosterone in the nuclear compartment, then it must reassociate with the chaperone complex to retain the ligand binding cleft in the correct conformation for ligand rebinding, receptor reactivation, and DNA binding. Therefore, the final set of experiments was to inhibit HSP90 with GA after completion of the first cycle of GR activation and inactivation but while all the GR were still within the nuclear compartment. This was an important aspect of the experimental design, because GA treatment is known to inhibit ligand binding and GR activation in the cytoplasmic compartment and thus cytoplasmic to nuclear translocation. [Figure 5](#F5){ref-type="fig"}A shows that GA treatment (postcorticosterone withdrawal) completely abrogated further responsiveness of GR to pulses of corticosterone. It should be noted that the absolute levels of nuclear GR are not yet depleted in the first 2 h of GA treatment (see [Fig. 3](#F3){ref-type="fig"}). These results strongly support a role for chaperone activity in GR reactivation by ligand within the nucleus, a function previously well described for HSP90 in the cytoplasm for the initial round of GR activation ([@B30]). Because GR action was completely inhibited at the first stage of ligand-induced activation, it was hypothesized that all subsequent transcriptional events would also be inhibited. The consequence of GA treatment on downstream transcriptional events was confirmed to be a complete ablation of ultradian cyclical transcriptional activity at the *PER1* gene. [Figure 5](#F5){ref-type="fig"} shows that the first pulse (before GA treatment) causes recruitment of GR to the chromatin template at the GRE site ([Fig. 5](#F5){ref-type="fig"}B), recruitment of CBP ([Fig. 5](#F5){ref-type="fig"}C) and p300 ([Fig. 5](#F5){ref-type="fig"}D), increased acetylation ([Fig. 5](#F5){ref-type="fig"}E), and a pulse of nascent *PER1* RNA production ([Fig. 5](#F5){ref-type="fig"}F). After GA treatment, neither GR, CBP, or p300 were detected at the GRE site, and acetylation and the transcription rate remained at low basal levels. All cyclical transcriptional activity was inhibited, consistent with a lack of GR responsiveness to pulsatile hormone addition.

![Inhibition of HSP90 with GA renders GR unable to be reactivated by subsequent pulses of CORT and ablates cyclical downstream transcriptional events. A, Treatment of AtT-20 cells with GA after nuclear translocation was complete and after GR dissociation from the DNA template (*i.e*. at 45 min after corticosterone withdrawal) resulted in failure of the GR to be subsequently reactivated by further GC pulses. Activated GR was measured in nuclear extracts in the TransAM assay. B, ChIP assay revealed that GR association with the *PER1* GRE followed the expected kinetics observed in [Fig. 1](#F1){ref-type="fig"} for the first pulse. After treatment with GA, GR could not be detected at the *PER1* GRE during the second corticosterone pulse. The HAT p300 (C) and CBP (D) were both recruited to the GRE, closely after GR. This association was maximal at 15 and 30 min but reduced to baseline levels by 60 min. The transient recruitment of p300 and CBP to the GRE was ablated after treatment with GA. E, The pulsatile changes in net lysine acetylation at the *PER1* GRE was negated by GA treatment. F, Pulsatile transcription (measured here by quantitative PCR of *PER1* hnRNA) was ablated by GA treatment. P, Pulse; Veh, vehicle.](zmg0061148340005){#F5}

Discussion
==========

Repeated pulses of natural GC ligand initiate and maintain rapid and transient pulsatile activation of GR, and cyclical changes in GR chromatin association profiles at specific DNA regulatory elements in endogenous GC regulated gene promoters. In the case of *PER1*, pulsatile GR action was associated with the consequent cyclical recruitment of CBP, p300, and RNA Pol2, cyclical increases in histone H4 acetylation, and pulses of nascent *PER1* RNA. Interestingly, the related steroid receptor, the estrogen receptor (ER), has been reported to act in a cyclical transcriptional mechanism. ER cycling on target gene promoters was shown to occur in an ordered, cyclical manner modulated by estradiol and other agonist compounds ([@B31], [@B32]). The cyclic assembly and disassembly during the hormonal response shows a periodicity of 40 min for estradiol-bound ER, with some of the cofactors reloading again within 2 h of the original hormone treatment. In stark contrast to the findings with ER, GR and its associated transcriptional coactivators have been shown to remain constantly loaded on the mouse mammary tumor virus promoter over 2 h during constant hormone treatment ([@B33], [@B34]). Taken together, these reports strongly suggest that ER exhibits an intrinsic cyclical activity, whereas GR does not. We therefore propose the alternative mechanism for GR function. Here, the ligand acts as the determining factor for cyclical activity at the target gene promoter. The stochastic GR action at the chromatin template, which has been so well elucidated by the Hager lab ([@B8], [@B9], [@B15], [@B34]), appears to work optimally with the deterministic pattern of pulsatile ligand exposure to establish and maintain this striking cyclical transcriptional activity.

Notably, the cyclical activation profile of GR to pulsatile GC administration was found to be independent of nuclear cytoplasmic shuttling. In fact, after the first pulse, GR remained confined to the nuclei of AtT-20 cells for several hours, consistent with the previously reported nuclear export rate of t~1/2~ = 8--9 h ([@B22], [@B35]). Our finding agrees with many reports derived from different methodologies ([@B25], [@B35], [@B36]), notably including a study describing continuous ligand responsiveness in a GR mutant selectively retained in the nucleus via addition of the heterologous simian virus 40 nuclear localization sequence ([@B37]). Our IN Cell 1000, high content imaging has enabled robust quantification of this phenomenon, because over 10,000 cells were analyzed simultaneously and without experimental bias ([@B21], [@B38]).

It has been appreciated for many years that the nuclear chaperone complex is critically important for nuclear retention of GR ([@B39]), because inhibition of HSP90 with GA significantly reduced GR nuclear localization. This study indicates that a significant proportion of "unchaperoned" nuclear GR appears to undergo some form of proteasome-dependent clearance, because pretreatment with the proteasome inhibitor MG132 greatly reduced the effect of GA on GR clearance from the nucleus and restored GR nuclear retention. These findings strongly implicate the HSP90 chaperone assembly involvement in retention of GR within the nucleus, enabling an intranuclear circuit capable of responding to pulsatile ligand exposure.

Although models describing an intranuclear recycling mechanism for GR have been in existence for over 10 yr ([@B25], [@B36], [@B39]), our study places the mechanism in a physiologically relevant context related to the naturally occurring ultradian GC secretory rhythm. The original studies by DeFranco and co-workers, based on a series of elegant experiments in digitonin-treated, cytosol-free cells, showed a deoxyribonuclease sensitive, high affinity binding of GR to the nucleus in the presence of GC. This changed to a more loosely associated binding after ligand washout. Upon hormone readdition, GR reacquired its deoxyribonuclease sensitive, high affinity state, thus providing compelling although indirect evidence of cycles of DNA association. Further evidence to support this model derives from live cell imaging studies from Hager and co-workers ([@B40]) showing green fluorescent protein-GR localized to an artificial array of GRE in a 200-copy tandem repeat of the mouse mammary tumor virus promoter. Stavreva *et al.* ([@B13]) have recently used this model system to investigate the effect of ultradian patterns of ligand exposure on GR activity and established a "gene pulsing" effect dependent on pattern of ligand exposure to the target cell and independent of cytoplasmic export. We have now extended this study to include pulse-directed GR activity on real GC target genes in physiologically relevant and functionally diverse GC target cell types. Direct evidence for defined cyclical changes in the set-point of GR\'s chromatin association activity, regulated by pulses of the natural GC corticosterone and cortisol, is presented. We further show that an exclusively intranuclear chaperone cycle is critically involved in generating nuclear GR responsiveness to pulsatile GC treatment.

Our data strongly support a model that places the HSP90/p23 molecular chaperone complex in the nuclear compartment and fundamental for GR intranuclear function. HSP90 and p23 have both been implicated in many diverse and significant chromatin-associated functions ([@B25], [@B29], [@B30], [@B35], [@B39]--[@B41]). We also present the first evidence for a significant physiological role of these molecular chaperones as key regulators of GR cyclical transcriptional activity during ultradian hormone rhythmicity. Our results strongly indicate that the chaperone activity of HSP90 is required for GR reactivation by ligand in the nucleus, because inhibition of HSP90 significantly attenuated GR responsiveness to subsequent pulses of corticosterone ([Fig. 5](#F5){ref-type="fig"}). We suggest that the function of the nuclear chaperone complex in this context is most likely to retain the GR ligand binding cleft in the correct conformation for ligand rebinding and receptor reactivation.

Our model for GR activation during basal pulsatility at the circadian peak is described in [Fig. 6](#F6){ref-type="fig"}. Here, the activity of GC target cells is regulated by discrete pulses of ligand in an intranuclear circuit mediated by the chaperone complex. The receptor exchanges rapidly with binding sites in accessible chromatin domains during the process of chromatin remodeling ([@B9], [@B12]); at some point during this exchange process, ligand is lost, and the receptor must reenter the chaperone cycle to rebind hormone. Each pulse-directed GR activation cycle initiates a new cycle of cofactor recruitment, histone acetylation, and transcriptional activity (at the *PER1* gene studied). Inhibition of intranuclear HSP90 inhibits the cyclical transcriptional process at the most fundamental stage, GR activation by ligand. These data highlight the key role of the molecular chaperone cycle in this cyclical transcriptional process. The optimal functioning of this finely regulated system is strictly dependent upon three critical and interrelated mechanistic factors: the stochastic action of GR, the deterministic action of ultradian ligand pattern, and the regulatory action of the HSP90 molecular chaperone circuit. The physiological outcome of this form of stringent temporal control of the transcriptional profile of target cells is to maintain a highly responsive system, optimal for meeting the rapidly changing demands of the organism.

![Model of intranuclear GR responsiveness to pulses of GC. The first pulse of endogenous GC, corticosterone or cortisol, resulted in nuclear translocation and enhanced association at specific GRE sequences at the chromatin template. p300 and CBP are recruited to this regulatory site, increasing acetylation at histone H4 and the association of activated RNA Pol2. At this phase (pulse peak), there is an increased rate of transcription of the PER1 gene. As hormone is cleared (the half-life of corticosterone is \<10 min *in vivo*), the cells can sense the declining levels of ligand, because the endogenous ligand off-rate from GR is relatively rapid. The mechanism underlying this acute response to declining ligand is the rapid GR cycling on chromatin (timescale sec). At each exchange event, there is a probability that ligand will be lost from GR. Unliganded GR will then reenter the chaperone cycle, with the reassociation of the molecular chaperones HSP90 and p23. Unliganded GR is then retained within the nuclear compartment in complex with these molecular chaperones. At this phase (pulse trough), GR and cofactors are not chromatin associated, and the acetylation state returns rapidly to basal levels. RNA Pol2 association at the promoter is also decreased to basal levels, and the transcription rate is low. The next pulse of ligand can activate the intranuclear pool of GR, enabling another cycle of transcriptional activity, because the chaperones hold the ligand binding cleft in the correct conformation. Inhibition of the HSP90 chaperone assembly affects the intranuclear chaperone cycle at multiple points. Inhibition of a productive HSP90-GR interaction prevents pulsatile GR reactivation by directly acting at the ligand binding step. Therefore, all cyclical transcriptional activities initiated by GR as a pioneer factor at the chromatin template ceases. NET, The amount of GR (measurable by ChIP) at the chromatin template at equilibrium position.](zmg0061148340006){#F6}

Materials and Methods
=====================

Cell culture
------------

Frozen stocks of the mouse corticotroph AtT-20 (D16v-F2), human HeLa, rat liver HTC, and human lung-derived A549 cell lines were obtained from the European Collection of Cell Cultures (Salisbury, UK). All cells were cultured in 75-cm^2^ tissue culture flasks incubated at 37 C in humidified air containing 5% (vol/vol) CO~2~ until the cells reached approximately 75% confluency. Culture media (DMEM with [l]{.smallcaps}-glutamine and 4.5 g/liter glucose; GIBCO, Paisley, UK), were supplemented with 10% (vol/vol) heat inactivated fetal calf serum (Sigma, Welwyn Garden City, UK), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (GIBCO). Before corticosterone treatment, the cultures were washed (3×) in PBS, and for 16--24 h before hormone treatments, cells were maintained in serum and phenol red-free DMEM/F12 medium (GIBCO) supplemented with 100 μg/ml BSA (fraction V) (GIBCO) and 10 μg/ml transferrin (Sigma). Hormone treatments (corticosterone, 100 n[m]{.smallcaps}; cortisol, 200 n[m]{.smallcaps}) and washes were also performed in this hormone-free culture medium formulation.

Nuclear extraction
------------------

Nuclear fractions were prepared as previously described ([@B42]). All procedures were performed at 4 C and on ice. Cells were lysed in 300 μl S1 buffer \[10 m[m]{.smallcaps} HEPES (pH 7.9), 10 m[m]{.smallcaps} KCl, 1.5 m[m]{.smallcaps} MgCl~2~, and 0.1 m[m]{.smallcaps} EDTA (pH 8)\], supplemented with 0.5 m[m]{.smallcaps} dithiothreitol, 0.2 m[m]{.smallcaps} Na orthovanadate, 2 m[m]{.smallcaps} NaF, 0.2% Nonidet P-40, and Complete Protease Inhibitor (Roche Diagnostics Ltd., UK). Nuclear proteins were extracted in 1.2 pellet volumes of S2 buffer \[10 m[m]{.smallcaps} HEPES (pH 7.9), 400 m[m]{.smallcaps} NaCl, 1.5 m[m]{.smallcaps} MgCl~2~, 0.1 m[m]{.smallcaps} EDTA (pH 8), and 5% glycerol\], supplemented with 0.5 m[m]{.smallcaps} dithiothreitol, 0.2 m[m]{.smallcaps} Na orthovanadate, 2 m[m]{.smallcaps} NaF, and Complete Protease Inhibitor and stored at −80 C. Protein concentrations were determined by bicinchoninic acid assay (Pierce, Rockford, IL).

GR-DNA binding assay
--------------------

A commercially available ELISA-based transcription factor binding assay kit (TransAM GR; Active Motif) was used to measure GRE binding activity for each nuclear sample. The amount of total protein loaded for each sample was determined by bicinchoninic acid assay, and as an additional normalization control to more accurately measure the integrity of each sample, an aliquot of nuclear extract from each sample was also processed for nuclear factor Y (NF-Y) DNA binding activity (TransAM NF-Y; Active Motif). NF-Y is a ubiquitous transcription factor that showed no significant difference between the treatment groups. DNA binding assay kits were used in accordance with the manufacturer\'s instructions. Briefly, nuclear extracts (20 μg for GR, 5 μg for NF-Y) were incubated in wells of the 96-well plates coated with GR or NF-YA binding consensus oligonucleotide sequence for 1 h, then incubated with the supplied primary anti-GR or NF-Y antibody (1:1000) for 1 h, then with a peroxidase-conjugated secondary antibody (1:1000) for 1 h. After the substrate was added, color development was read at 450 nm, and the OD of both GR and NF-Y were recorded. The OD results obtained from the GR assay were normalized relative to OD results from the NF-Y assay. Data were then expressed as fold induction relative to time zero.

Chromatin immunoprecipitation
-----------------------------

ChIP was performed using buffers prepared according to the EZ ChIP kit (Upstate, Charlottesville, VA) with some modification to the protocol. A wash in PBS (pH 7.4) terminated treatment before cells were fixed in 1% (vol/vol) formaldehyde in PBS (10 min, room temperature). Cross-linking was quenched by addition of glycine to 0.125 [m]{.smallcaps} for 5 min, before fixing solution was removed fully by three washes in ice-cold PBS supplemented with 2 m[m]{.smallcaps} NaF and 0. m[m]{.smallcaps} Na orthovanadate. Cells were scraped into sodium dodecyl sulfate lysis buffer supplemented with NaF, Na orthovanadate, and Complete Protease Inhibitor, then sonicated with a Branson Sonifier 450 to an average chromatin fragment size of 2 kb with 10-sec pulses at 10% output; 70 μg chromatin per ChIP reaction was diluted 1:10 in ChIP dilution buffer and rotated 2 h at 4 C with 60 μl protein A agarose beads (Upstate). Precleared lysate was rotated at 4 C overnight with 2 μg H-300 rabbit anti-GR (AtT-20 and HeLa) or 2 μg M-20 rabbit anti-GR (HTC). Negative controls were incubated with 2 μg nonimmune rabbit IgG (all from Santa Cruz Biotechnology, Inc., Santa Cruz, CA) under identical conditions. Antibody-GR-DNA complexes were collected on 60 μl protein A agarose beads (2 h, 4 C), then washed once with the low salt buffer, twice with a 300 m[m]{.smallcaps} NaCl variant on the kit high salt buffer, once with LiCl buffer, and twice with TE buffer (pH 8.0) to remove nonspecific binding. Complexes were eluted off beads by shaking in elution buffer (0.1 m[m]{.smallcaps} NaHCO~3~ and 1% sodium dodecyl sulfate) before reversal of cross-links overnight at 65 C under high salt (0.2 [m]{.smallcaps} NaCl) conditions. Ribonuclease (Roche Diagnostics Ltd.) and proteinase K (Sigma) digestion removed specific contaminants before eluted DNA was extracted once in 25:24:1 phenol-chloroform-isoamyl alcohol and once in 24:1 chloroform-isoamyl alcohol (Sigma). DNA was ethanol precipitated overnight, washed in 70% ethanol, and finally eluted in nuclease-free water (Ambion, Huntingdon, UK) ready for PCR amplification. Primers (Invitrogen, Paisley, UK) were designed in regions flanking described GRE in the *PER1* and *Mt1* and *POMC* promoters, and the GRE at −5.4 kb in the *TAT* promoter. Amplification was inside the linear range.

Primer sequences 〈m, mus; h, human; r, rat):

*mPOMC*, forward (F) CGCTAAGCCTCTGTCCAGTT

*mPOMC*, reverse (R) GTCCCTGTCGCTCTTCTCTC

*mMTI*, F GGCTCTGCAGATGACACAGA

*mMTI*, R GGGTGTTTGCCAAGTAGGAA

*hPER1*, F GCAGATGGGAGTCCTGAAAA

*hPER1*, R GAGGCTGGAGAGACTGGAGA

*rTAT*, F GACTCCTCTGGCTTTCATCG

*rTAT*, R TGCATAACTGTGGCAACCAT.

Cofactor and acetylation ChIP assays
------------------------------------

Replicate chromatin samples were prepared as above and used for ChIP assays with antiacetylated lysine (9441L; Cell Signaling, Beverly, MA), anti-CBP (sc-369X; Santa Cruz Biotechnology, Inc.), p300 (sc-584X; Santa Cruz Biotechnology, Inc.), anti-RNA Pol2 (Active Motif AM39233), and antiacetylated histone H4 (Active Motif AM39243).

The amount of immunoprecipitated DNA resulting from each ChIP was analyzed by quantitative PCR using Sybr Green assay (Applied Biosystems, Foster City, CA) with the following primers:

*mPER1*, F CAGGAATTTTTGGCTTTTGTACAG

*mPER1*, R GCCCAGGACATGCACACA.

Preparation of cell cultures for IN Cell image and data acquisition
-------------------------------------------------------------------

For IN Cell imaging experiments, AtT-20 Cells were grown in 96-well Corning Costar plates (Appleton Woods, Birmingham, UK) that had been precoated with Poly-[d]{.smallcaps}-lysine (Sigma) and seeded to 5000 cells per well. For hormone withdrawal experiments (unless specified), cells were pretreated with 100 n[m]{.smallcaps} corticosterone for 1 h, washed with PBS (3×), and then maintained in hormone-free culture medium.

Immunocytochemistry
-------------------

Treatments were terminated by washing the cultures in PBS (pH 7.4) and were then fixed using 4% (wt/vol) paraformaldehyde (Sigma) in 0.1 [m]{.smallcaps} PBS for 20 min. After two more washes with PBS, cells were permeablized with 0.1% (vol/vol) Triton X-100/PBS (Sigma) for 3 min and washed (2×) in PBS. Nonspecific protein binding was blocked with 1% (wt/vol) BSA/PBS for 20 min at room temperature before incubating with the primary antibody. GR immunoreactivity was detected using M-20 rabbit anti-GR (Santa Cruz Biotechnology, Inc.), at a dilution of 1:500 in 1% (wt/vol) BSA/PBS. After overnight incubation at 4 C, the cells were washed (3×) with PBS and stained with donkey antirabbit Alexa Fluor 488-conjugated IgG (Invitrogen, Molecular Probes, Paisley, UK) at 1:500 dilution in 1% (wt/vol) BSA/PBS and incubated in the dark for a further 2 h at room temperature. Before nuclear staining, the cells were washed in PBS and then counterstained by incubating in Hoechst 33342 (Invitrogen, Molecular Probes) at 3:10,000 in 0.1 [m]{.smallcaps} PBS for 10 min followed by a further wash in PBS before IN Cell analysis.

Demarcation and quantification of nuclear and cytoplasmic compartments
----------------------------------------------------------------------

Digital images were acquired from four designated fields per well giving a total collection area of not less than 2.4 mm^2^. Typically, images of 1000--4000 cells per well were captured using a ×10 (numerical aperture, 0.45) objective (plan apochromat) and D360-nm (Hoechst) and S475-nm (Alexa Fluor 488) excitation filters. Images of nuclear and cytoplasmic regions were monitored through 460- and 535-nm emission filters, respectively, and quantified using the IN Cell 1000 Analyzer software (Dual Area Analysis Algorithm version 1.0; GE Healthcare). Background fluorescence from surrounding cell-free regions was subtracted to provide the fluorescence intensity for the cytosol or nucleus. These values were then used to calculate the GR nuclear and cytoplasmic fluorescence intensities for each individual cell.

Statistical procedure and data presentation
-------------------------------------------

Unless otherwise stated, figures show data from four to eight replicate wells per treatment condition (4000 cells per well) (TransAM, IN Cell), data pooled from three separate experiments (IN Cell), or a single representative experiment of at least three with similar outcomes (ChIP). All data are expressed as mean ± [sem]{.smallcaps}. Curve fitting for gene expression experiments was performed with GraphPad Prism 4 (GraphPad Software, San Diego, CA).

Abbreviations: CBPCREB binding proteinChIPchromatin immunoprecipitationCHXcyclohexamideCREBcAMP response element-binding proteinERestrogen receptorFforwardGAgeldanamycinGCglucocorticoidGRGC receptorGREGC regulatory elementhhumanHAThistone acetyl transferaseHSP90heat shock protein 90mmus*MT1*metallothionein INF-Ynuclear factor Y*PER1*Period 1*POMC*proopiomelanocortinrratRreverseRNA Pol2RNA polymerase 2*TAT*tyrosine aminotransferaseWGAwheat germ agglutinin.
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